dr. axel grothey examines the use of adjuvant oxaliplatin in colon cancer
Published 11 years ago • 870 plays • Length 0:57Download video MP4
Download video MP3
Similar videos
-
1:35
dr. axel grothey on bevacizumab beyond progression in metastatic colorectal cancer
-
29:15
icaho20 - asco direct™ highlights - dr. axel grothey - colorectal cancer
-
6:02
introduction and overview of adjuvant treatment in colorectal cancer, part i
-
1:53
the role of sidedness in colorectal cancer
-
1:27
dr. axel grothey on differences between correct and concur studies in mcrc
-
24:57
attr amyloidosis and the gut
-
23:12
md insights: dr. emre gorgun
-
12:48
oxaliplatin toxicology presentation - samantha kinley
-
11:50
colon cancer management - dr. axel grothey, part 1
-
1:43
axel grothey, md | what is signatera?
-
16:41
can we refine the selection for adjuvant treatment in stage ii colon cancer?
-
1:47
dr. axel grothey on the time course of regorafenib-associated adverse events
-
2:04
dr. grothey on left- versus right-sided tumors in crc
-
2:03
dr. axel grothey on the side effect profile of regorafenib in metastatic colorectal cancer
-
1:48
dr. grothey discusses novel agents for colorectal cancer
-
24:52
icaho 2017 - dr. axel grothey
-
0:56
dr. chan discusses the adjuvant colorectal no147 trial
-
11:41
treating unresectable metastatic colorectal cancer
-
13:18
managing adjuvant treatment in colorectal cancer, part ii
-
5:34
tumor biology and sidedness in colon cancer
-
0:57
dr. grothey on biomarkers to inform metastatic crc treatment decisions
-
6:17
colorectal cancer & ctdna updates with dr. axel grothey